Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 238.2 USD 1.43% Market Closed
Market Cap: 172B USD
Have any thoughts about
Danaher Corp?
Write Note

Danaher Corp
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Danaher Corp
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Danaher Corp
NYSE:DHR
Retained Earnings
$43.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
8%
Thermo Fisher Scientific Inc
NYSE:TMO
Retained Earnings
$51.4B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
18%
West Pharmaceutical Services Inc
NYSE:WST
Retained Earnings
$3.9B
CAGR 3-Years
18%
CAGR 5-Years
21%
CAGR 10-Years
16%
Mettler-Toledo International Inc
NYSE:MTD
Retained Earnings
$8.1B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
14%
Agilent Technologies Inc
NYSE:A
Retained Earnings
$750m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
IQVIA Holdings Inc
NYSE:IQV
Retained Earnings
$5.6B
CAGR 3-Years
43%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Danaher Corp
Glance View

Economic Moat
Narrow
Market Cap
172B USD
Industry
Life Sciences Tools & Services

Once upon a time, back in 1984, two brothers, Steven and Mitchell Rales, envisioned a company that would revolutionize the manufacturing sphere, setting the roots for what would become Danaher Corporation. Born from the acquisition of a real estate investment trust, they pivoted to a broader industrial manufacturing approach, aligning themselves with the then unique concept of lean manufacturing and continuous improvement – known as the Danaher Business System (DBS). This philosophy helped them transform Danaher into an assembly of high-performance companies. Over the decades, the corporation honed its focus, shedding non-core assets, and refining its portfolio to center on biotechnology, life sciences, environmental and applied solutions, and diagnostics. Through strategic acquisitions and relentless innovation, Danaher has continued to evolve, constantly reshaping itself to meet the demands of critical sectors. Today, Danaher's operations are driven by three powerful segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Its Life Sciences segment enables breakthrough discoveries that advance scientific research, healthcare, and more. Meanwhile, the Diagnostics division delivers critical tools that aid clinical laboratories and physicians in patient care, offering blood and infection analysis technologies, among others. Finally, Environmental & Applied Solutions focuses on water quality and product-identification services, crucial for maintaining health and safety standards across industries. By continually investing in innovation and focusing on operational efficiencies through DBS, Danaher not only positions itself as a leader in these sectors—it harnesses market needs into profitable solutions, ensuring its growth and stability in a competitive global market.

DHR Intrinsic Value
192.01 USD
Overvaluation 19%
Intrinsic Value
Price

See Also

What is Danaher Corp's Retained Earnings?
Retained Earnings
43.3B USD

Based on the financial report for Sep 27, 2024, Danaher Corp's Retained Earnings amounts to 43.3B USD.

What is Danaher Corp's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
8%

Over the last year, the Retained Earnings growth was 2%. The average annual Retained Earnings growth rates for Danaher Corp have been 12% over the past three years , 10% over the past five years , and 8% over the past ten years .

Back to Top